Semaglutide Dosage Conversions: ml to mg Guide

Last reviewed: May 23, 2026

Last updated: May 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The relationship between semaglutide milligrams and milliliters depends on the concentration of your specific formulation. Standard compounded semaglutide typically delivers 1 mg per approximately 0.17 ml (or about 6 mg/ml concentration), though compounding pharmacies may prepare varying concentrations based on provider guidance.

Precise dosage understanding matters because semaglutide titration begins low and increases gradually over weeks. Knowing your formulation's concentration ensures you inject the correct amount at each step, reduces medication waste, and supports clearer conversations with your healthcare provider about dose adjustments tailored to your individual response.

Concentration Basics: Why ml-to-mg Conversion Varies

Semaglutide concentration is expressed as micrograms or milligrams per milliliter (mcg/ml or mg/ml). A 6 mg/ml concentration means each milliliter contains 6 mg of active semaglutide. Compounding pharmacies prepare formulations at different strengths based on dosing schedules and patient needs, so your specific conversion ratio depends on your pharmacy's preparation.

Common compounded semaglutide concentrations include 2 mg/ml, 4 mg/ml, and 6 mg/ml. Higher concentrations mean you inject smaller volumes at each dose, which some patients find convenient. Your provider typically specifies concentration when writing the prescription, and the pharmacy provides detailed labeling to clarify the exact ml-to-mg relationship for your vial.

Standard Dosing Conversions and Titration Schedule

Semaglutide therapy follows a structured titration protocol, starting at the lowest dose and increasing every 7 days or per provider guidance. Early doses are measured in micrograms (0.25 mg, 0.5 mg, 1 mg), while maintenance doses may reach 2.4 mg weekly. Understanding your formulation's concentration allows you to accurately measure each titration step.

Typical Maintenance Dose (mg)	ml Needed (at 6 mg/ml)	ml Needed (at 4 mg/ml)	Clinical Context
0.25	0.04 ml	0.06 ml	Initial dose, week 1-4
0.5	0.08 ml	0.13 ml	Week 5-8 titration
1.0	0.17 ml	0.25 ml	Week 9-12 maintenance
2.4	0.40 ml	0.60 ml	Maximum weekly dose

Measuring Accuracy: Tools and Techniques for Safe Dosing

Accurate measurement requires appropriate syringes with clear markings in both ml and micro-units. Most providers recommend using insulin syringes or 1 ml syringes calibrated to 0.01 ml increments, paired with sterile needles for subcutaneous injection. Never estimate doses or reuse needles across multiple injections.

Your pharmacy should provide a detailed instruction sheet showing the exact volume for each dose week. Keep this documentation accessible during your entire titration phase. If volume measurements seem unclear, contact your pharmacy or provider before injecting—accurate dosing is critical for both safety and therapeutic response.

Provider-Guided Dosing Adjustments and Individual Response Variation

Semaglutide response varies significantly between individuals due to metabolism, gut sensitivity, and genetic factors affecting GLP-1 receptor signaling. Some patients reach therapeutic effect at lower doses, while others require higher doses. Your provider may adjust your titration timeline or concentration based on side effects, appetite suppression, or clinical goals.

Dose adjustments should only occur under provider supervision. If you experience concerning side effects or lack expected response, communicate directly with your healthcare team rather than self-adjusting volume measurements. Provider-guided protocols ensure your dose remains safe while optimizing your individual therapeutic outcome.

How PlexusDx Supports a More Personalized Approach

Individual variation in semaglutide response relates partly to genetic factors affecting GLP-1 receptor function and glucose metabolism. Variants in the GLP1R and GIPR genes may help provide context for why some patients respond robustly at lower doses while others require higher doses to achieve similar appetite suppression and metabolic benefits.

PlexusDx's Precision Peptide Genetic Test reveals predispositions in key peptide pathways, including GLP-1 and GIP receptor genetics (GLP1R rs6923761, GIPR rs1800437). This genetic context, interpreted with your provider, can support a more informed conversation about your expected dose range and potential side effect sensitivity, though genetics does not predict your exact semaglutide response.

Understanding both your formulation's concentration and your genetic predispositions enables a more personalized dosing conversation with your provider. Together, these insights—combined with your clinical history and real-time response monitoring—inform whether standard titration protocols fit your needs or if adjustments are warranted.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.